In this episode of The Joe Rogan Experience, Ben Lamm, CEO of Colossal Biosciences, details his company's pioneering efforts in de-extinction—the process of reviving extinct species like the woolly mammoth and Tasmanian tiger through advanced genetic engineering. He reveals how Colossal utilizes modern technologies such as CRISPR, cloning, and AI to assemble ancient genomes and resurrect extinct traits in living organisms.
Lamm explores the potential ecological impacts and conservation benefits of de-extinction. He also addresses the philosophical debates surrounding the definition of a "true" original species and the regulatory hurdles facing this emerging field. Colossal's work raises intriguing scientific and ethical questions about our ability to reshape the natural world.
Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Ben Lamm, CEO of Colossal Biosciences, introduces the first company dedicated to de-extinction and species preservation. Colossal aims to revive extinct species like the woolly mammoth, Tasmanian tiger, and dire wolf using advanced genetic technologies.
Lamm discusses assembling ancient DNA, mapping living relatives, and using CRISPR to edit key extinct traits into organisms. Colossal utilizes multiplex editing and screening to ensure healthy outcomes. Lamm hints at ancestral genome engineering to recreate dinosaur-like species.
Lamm explains how reintroducing mammoths could boost Arctic environments by sequestering carbon and enhancing habitat diversity, drawing on Sergei Zimov's work at Pleistocene Park. The loss of the thylacine (Tasmanian tiger) may have enabled the Devil Facial Tumor Disease spread in Tasmania.
For every de-extinction effort, Colossal biobanks genetic samples of endangered relatives to aid conservation. For example, Colossal supports the genetic rescue of the Northern White Rhino and Red Wolf populations.
Colossal uses CRISPR to engineer contemporary organisms like mice to express ancient phenotypes like woolly mammoth traits, demonstrating their genome engineering capabilities.
Leveraging AI and computational biology, Colossal efficiently assembles ancient genomes from scarce DNA samples and maps complex, multi-gene traits. Their AI techniques enable amplifying DNA from unique ancient sources.
Critics argue Colossal's de-extinct animals are genetically modified, not true originals, highlighting philosophical discussions around species definitions based on reproductive isolation.
Lamm shares frustrations with government hesitation towards novel technologies like de-extinction cloning, necessitating lengthy studies despite proof-of-concepts.
Colossal aims for transparency, engaging indigenous groups and stakeholders. Lamm stresses Colossal focuses only on de-extinction for conservation, not unethical human enhancement applications.
1-Page Summary
Ben Lamm, CEO, and co-founder of Colossal Biosciences, speaks about the world's first company dedicated to de-extinction and species preservation.
Colossal has made significant investments in marsupial research and is working on reviving species such as the woolly mammoth, Tasmanian tiger, and dodo. The company has garnered involvement from the MHA Nation for the preservation of species like the dire wolf.
Ben Lamm discusses the complex process of extracting and assembling ancient DNA, using genetic technologies to map, edit, and bring extinct species back to life, with a focus on the key phenotypic di ...
De-extinction Efforts and Methods
Ben Lamm discusses the scientifically guided return of extinct species to the wild, focusing on its potential to rejuvenate ecosystems and aid in conservation efforts.
Rewilding efforts using extinct species draw insights from the successful reintroduction of wolves, Lamm explains. This intervention altered elk behaviors and ultimately reshaped river courses through trophic cascades.
Ecological modeling supports the reintroduction of mammoths, which could net positive ecosystem benefits. Sergei Zimov's work at Pleistocene Park exemplifies the approach, where rewilding Northern Siberia with cold-tolerant megafauna can revitalize ecosystems, add biodiversity, and contribute to carbon sequestration by maintaining cold ground temperatures in winter.
The case of the thylacine, Lamm asserts, hints at combating the spread of Devil Facial Tumor Disease. By reintroducing this predator, which would naturally target sick Tasmanian devils, a balance could be restored that may check disease proliferation.
Lamm emphasizes Colossal's dual focus on both de-extinction and the conservation of endangered species. With every de-extinction project, a species preservation initiative is paired. For example, Colossal's technology supports the genetic rescue of the Northern White ...
Conservation and Ecological Impacts of Reviving Extinct Species
Colossal Biosciences is spearheading efforts in de-extinction and conservation using next-generation genome engineering tools.
Utilizing CRISPR and other genetic editing technologies, Colossal Biosciences aims to resurrect extinct species by engineering contemporary species to express ancient phenotypes.
Colossal is employing multiplex editing tools to make precise genetic edits, as they've demonstrated by producing "woolly mice"—mice with engineered traits of the woolly mammoth, which served as a proof of concept. Ben Lamm of Colossal discusses the complexities of such genome engineering, such as the need to manage gene expression carefully to prevent increasing susceptibility to disease, highlighting the edits needed to express woolly mammoth traits in mice. Joe Rogan mentions "waking up" dormant genes, suggesting that techniques like CRISPR are used to activate certain genes. Lamm also acknowledges the potential of these technologies to produce organisms reminiscent of those depicted in movies like Jurassic Park.
Colossal leverages AI and computational biology in conjunction with CRISPR to efficiently assemble genomes from ancient DNA samples, mapping complex traits that involve clusters of genes.
Colossal Biosciences is pushing the envelope in extracting and amplifying DNA from ancient specimens, working with museums to obtain unique samples like giant sloth feces. Ben Lamm explains that they use AI and software to read entire genomes multiple times and fill in gaps, which suggests a sophisticated approach to assembling fragmented ancient DNA. This process not only supports de-extinction efforts but also contributes to understanding genetic resistance, such as their study on the genetic mutation that provides certain South American mammals and s ...
Technological Advancements in Synthetic Biology and Genetic Engineering
The conversation featuring Joe Rogan and Ben Lamm of Colossal Biosciences delves into the nuanced debates and challenges surrounding the growing field of de-extinction.
Lamm discusses the complexities of what constitutes a species, pointing out that there is no consensus among scientists. Some paleontologists focus on tooth morphology, while others use reproductive isolation as the benchmark. The critics compare Colossal’s de-extinct animals to genetically modified organisms, not true originals. Lamm touches on philosophical arguments that arise when discussing if an organism that can't breed with another due to genetic modifications is indeed its own species. These viewpoints highlight the crux of debate about whether the resulting animal from de-extinction efforts, like mammoths and dire wolves, is a true original or a human construct.
Ben Lamm shares his frustration with government officials who, despite being shown a cloned wolf, declared the need for a lengthy study to understand if cloning wolves is possible. This indicates the cautious stance of regulatory bodies towards unproven technologies like de-extinction. It also underscores the difficulties Colossal faces in gaining acceptance for their work.
Lamm stresses Colossal's intent to be open-source with their clone-from-blood model and plans to collaborate with various groups, including the Department of the Interior, academics, private landowners, indigenous people, and governments. He explicitly mentions their effort to engage stakeholders in their thylacine project, indicating an endeavor towards transparency and cooperation amid the company's pioneering efforts.
Joe Rogan rai ...
Ethical, Regulatory, and Societal Considerations Around De-extinction
Download the Shortform Chrome extension for your browser